share_log

Cantor Fitzgerald Assumes Alaunos Therapeutics at Overweight, Announces Price Target of $3

Cantor Fitzgerald Assumes Alaunos Therapeutics at Overweight, Announces Price Target of $3

坎托·菲茨杰拉德假设Alaunos Therapeutics处于增持状态,宣布目标股价为3美元
Benzinga Real-time News ·  2022/07/15 08:40

Cantor Fitzgerald analyst Prakhar Agrawal assumes Alaunos Therapeutics (NASDAQ:TCRT) with a Overweight rating and announces Price Target of $3.

坎托·菲茨杰拉德分析师普拉哈尔·阿格劳瓦尔假设Alaunos Therapeutics(纳斯达克股票代码:TCRT)的评级为增持,并宣布目标股价为3美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发